Abderrahman Bouassab
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abderrahman Bouassab has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Francesco Cacciola
Messina Institute of Technology c/o Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale G. Palatucci 13, 98168 Messina, Italy
1 shared publication - Hammadi El Farissi
Chemical Engineering for Resources Valorization Group (UAE/L01FST), Faculty of Science and Technology, Abdelmalek Essaadi University, Tangier 90002, Morocco
1 shared publication - Mohamed Chabbi
Department of Chemistry, Faculty of Science and Technology of Tangier, Abdelmalek Essaâdi University, Tetouan 93000, Morocco
1 shared publication - Narjisse Mokhtari
Laboratory of Physical Chemistry of Materials, Natural Substances and Environment. Faculty of Sciences and Technologies of Tangier. Abdelmalek Essaadi University, Tetouan, Morocco
1 shared publication - Yousra Mdarhri
Department of Chemistry, Faculty of Science and Technology of Tangier, Abdelmalek Essaâdi University, Tetouan 93000, Morocco
1 shared publication
Latest Publications
- Open Access
Sustained Antifungal Protection of Peanuts Using Encapsulated Essential Oils
Essential oils (EOs) are promising bio-preservatives for oilseeds; however, their high volatility and strong aroma limit practical applications. In this study, we developed a dual-size microencapsulated formulation of oregano (Origanum compactum) and myrtle (Myrthus communis) EOs (75:25, w/w) using gelatin–gum arabic complex coacervation, and evaluated its antifungal efficacy and effect on seed viability in peanuts. GC-MS analysis of the EO blend identified carvacrol (33.83%) as the dominant constituent. The microcapsules exhibited an encapsulation efficiency of 83.56% and were produced in a 70% small/30% large particle ratio to ensure both immediate and sustained vapor release. In vapor-phase assays against toxigenic A. flavus (RP-6), both free and encapsulated EOs inhibited fungal growth in a dose-dependent manner and achieved complete suppression at concentrations ≥0.2 µL mL−1, whereas the wall material alone showed no activity. In a 120-day microcosm storage experiment (0.2 mg EO g−1 kernels; 0.96 mg microcapsules g−1), treated peanuts showed an immediate reduction in total fungal load from 3.52 to 1.48 log10 CFU g−1 (≈58%), which stabilized near 1.42–1.43 log10 CFU g−1 up to 90 days, while the control samples increased to 4.25 log10 CFU g−1 by day 120. The formulation effectively suppressed major storage fungi, including Aspergillus sections Flavi and Nigri, Penicillium spp., Rhizopus, Fusarium, and Alternaria. The antioxidant activity (DPPH assay) was retained after encapsulation (IC50: 0.52 mg mL−1 encapsulated vs. 0.58 mg mL−1 free). Germination power remained comparable to the control throughout storage (≈50–52%), indicating no adverse impact on seed viability. These findings demonstrate that vapor-active, dual-size microencapsulation of oregano-myrtle EOs offers a practical and sustainable approach to enhance peanut safety during storage without compromising germination potential.
Open AccessSustained Antifungal Protection of Peanuts Using Encapsulated Essential Oils
Essential oils (EOs) are promising bio-preservatives for oilseeds; however, their high volatility and strong aroma limit practical applications. In this study, we developed a dual-size microencapsulated formulation of oregano (Origanum compactum) and myrtle (Myrthus communis) EOs (75:25, w/w) using gelatin–gum arabic complex coacervation, and evaluated its antifungal efficacy and effect on seed viability in peanuts. GC-MS analysis of the EO blend identified carvacrol (33.83%) as the dominant constituent. The microcapsules exhibited an encapsulation efficiency of 83.56% and were produced in a 70% small/30% large particle ratio to ensure both immediate and sustained vapor release. In vapor-phase assays against toxigenic A. flavus (RP-6), both free and encapsulated EOs inhibited fungal growth in a dose-dependent manner and achieved complete suppression at concentrations ≥0.2 µL mL−1, whereas the wall material alone showed no activity. In a 120-day microcosm storage experiment (0.2 mg EO g−1 kernels; 0.96 mg microcapsules g−1), treated peanuts showed an immediate reduction in total fungal load from 3.52 to 1.48 log10 CFU g−1 (≈58%), which stabilized near 1.42–1.43 log10 CFU g−1 up to 90 days, while the control samples increased to 4.25 log10 CFU g−1 by day 120. The formulation effectively suppressed major storage fungi, including Aspergillus sections Flavi and Nigri, Penicillium spp., Rhizopus, Fusarium, and Alternaria. The antioxidant activity (DPPH assay) was retained after encapsulation (IC50: 0.52 mg mL−1 encapsulated vs. 0.58 mg mL−1 free). Germination power remained comparable to the control throughout storage (≈50–52%), indicating no adverse impact on seed viability. These findings demonstrate that vapor-active, dual-size microencapsulation of oregano-myrtle EOs offers a practical and sustainable approach to enhance peanut safety during storage without compromising germination potential.